Recombinant Human FGF-2/FGF basic/FGFb Protein (aa 1-155) (Q65I, C96S, N111G)

CAT:
763-PKSH033502-01
Size:
10 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Human FGF-2/FGF basic/FGFb Protein (aa 1-155) (Q65I, C96S, N111G) - image 1

Recombinant Human FGF-2/FGF basic/FGFb Protein (aa 1-155) (Q65I, C96S, N111G)

  • Background:

    Fibroblast growth factors (FGF) are a family of heparin-binding secreted proteins that stimulate cell proliferation and differentiation in a wide variety of tissues. FGFs play important roles in diverse biological functions both in vivo and in vitro; including mitogenesis; cellular migration; differentiation; angiogenesis; and wound healing. Human embryonic stem cell (hESC) cultures require FGF basic (also known as FGF-2 or bFGF) in cell culture media to remain in an undifferentiated and pluripotent state. Thermostable FGF basic was engineered for enhanced stability in culture media; without modification of its biological function. FGF basic is a required component of stem cell culture media for maintaining cells in an undifferentiated state. Because FGF basic is unstable; daily media changes are needed. The thermostable FGF basic that supports a 2-day media change schedule; so no media changes are required over a weekend. This thermostable FGF basic was more stable than FGF basic in biochemical studies; and maintained cell growth; pluripotency and differentiation potential with a 2-day feeding schedule.
  • Abbreviation:

    FGF-2, FGF basic, FGFb
  • Synonyms:

    Basic fibroblast growth factor; FGF-2; FGF2; FGFB; Fibroblast growth factor 2; HBGF-2; Heparin-binding growth factor 2; bFGF
  • UniProt:

    P09038
  • Accession Number:

    BAG70264.1
  • Expression System:

    E. coli
  • Tag:

    None
  • Sequence:

    Met1-Ser155
  • Field of Research:

    Cardiovascular, Signal Transduction, Neuroscience, Stem Cells, Cancer, Developmental Biology
  • Endotoxin:

    < 1.0 EU per μg of the protein as determined by the LAL method.
  • Purity:

    > 95 % as determined by reducing SDS-PAGE.
  • Bioactivity:

    Not validated for activity
  • Reconstitution:

    Please refer to the printed manual for detailed information.
  • Shipping Conditions:

    This product is provided as lyophilized powder which is shipped with ice packs.
  • Storage Conditions:

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
  • Calculated Molecular Weight:

    17.2 kDa
  • Observed Molecular Weight:

    16 kDa
  • Formulation:

    Lyophilized from a 0.2 µm filtered solution of 20mM Tris, 5% sucrose, 0.02% Tween 80, pH 8.0.
    Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
    Please refer to the specific buffer information in the printed manual.
  • Species:

    Human